Bard Financial Services Inc. purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 2,640 shares of the healthcare conglomerate’s stock, valued at approximately $926,000.
Several other large investors have also recently bought and sold shares of the company. FMR LLC boosted its stake in shares of UnitedHealth Group by 0.6% in the 4th quarter. FMR LLC now owns 52,565,986 shares of the healthcare conglomerate’s stock valued at $18,433,841,000 after purchasing an additional 295,642 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its stake in UnitedHealth Group by 5.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 38,003,233 shares of the healthcare conglomerate’s stock worth $13,318,678,000 after acquiring an additional 1,881,407 shares in the last quarter. Alliancebernstein L.P. boosted its stake in UnitedHealth Group by 5.2% during the fourth quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock worth $4,027,639,000 after acquiring an additional 569,142 shares in the last quarter. Norges Bank bought a new position in UnitedHealth Group during the fourth quarter worth $3,397,896,000. Finally, Bank of New York Mellon Corp boosted its stake in UnitedHealth Group by 2.4% during the fourth quarter. Bank of New York Mellon Corp now owns 8,858,179 shares of the healthcare conglomerate’s stock worth $3,106,385,000 after acquiring an additional 207,865 shares in the last quarter. 86.03% of the stock is currently owned by institutional investors.
In other UnitedHealth Group news, CAO Thomas E. Roos sold 619 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total transaction of $200,494.10. Following the transaction, the chief accounting officer now directly owns 31,908 shares of the company’s stock, valued at $10,335,001.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction on Thursday, February 11th. The stock was sold at an average price of $335.80, for a total transaction of $1,679,000.00. Following the completion of the transaction, the director now directly owns 153,953 shares in the company, valued at $51,697,417.40. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 9,619 shares of company stock valued at $3,292,774. 0.80% of the stock is currently owned by company insiders.
Shares of UnitedHealth Group stock opened at $365.64 on Thursday. UnitedHealth Group Incorporated has a 1 year low of $246.26 and a 1 year high of $380.50. The firm has a market cap of $345.65 billion, a PE ratio of 21.00, a PEG ratio of 1.55 and a beta of 0.74. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82. The company has a 50 day simple moving average of $351.44 and a two-hundred day simple moving average of $339.34.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 19th. The healthcare conglomerate reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.39 by $0.13. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business had revenue of $65.47 billion during the quarter, compared to analyst estimates of $64.98 billion. During the same period in the previous year, the business posted $3.90 earnings per share. UnitedHealth Group’s revenue for the quarter was up 7.5% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 16.75 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Shareholders of record on Monday, March 15th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 annualized dividend and a yield of 1.37%. UnitedHealth Group’s payout ratio is presently 33.09%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Featured Article: Market Capitalization – What it Means for Investors
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.